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Thrombus volume is associated with
cardiovascular events and aneurysm growth in
patients who have abdominal aortic aneurysms
Adam Parr, MBBS (Hons), Moira McCann, PhD, Barbara Bradshaw, RGN,
Anwar Shahzad, MBBS, MRCP UK, Petra Buttner, PhD, and Jonathan Golledge, MChir, Townsville,
Queensland, Australia
Background: Patients with abdominal aortic aneurysms (AAA) are predisposed to cardiovascular events and often
experience continual expansion of their aneurysm. Cardiovascular events and expansion rates are positively correlated
with aneurysm size. AAA is usually associated with intraluminal thrombus, which has previously been implicated in AAA
pathogenesis. This study prospectively assessed the association of infrarenal abdominal aortic thrombus volume with
cardiovascular events and AAA growth.
Methods: Ninety-eight patients with AAAs underwent computed tomography angiography (CTA). The volume of infrarenal
aorta thrombus was measured by a previously validated technique. Patients were monitored prospectively for a median of 3
years (interquartile range [IQR], 2.0-3.6 years), and cardiovascular events (nonfatal stroke, nonfatal myocardial infarction,
coronary revascularization, amputation, and cardiovascular death) were recorded. Of the original patients, 39 underwent
repeat CTA a median of 1.5 years (IQR, 1.1-3.3 years) after entry to the study. Kaplan-Meier and Cox proportional analysis
were used to examine the association of aortic thrombus with cardiovascular events and average weighted AAA growth.
Results: There were 28 cardiovascular events during follow-up. The incidence of cardiovascular events was 23.4% and
49.2% for patients with small (smaller than the median) and large (median or larger) volumes of aortic thrombus,
respectively, at 4 years (P  .040). AAA thrombus volume of median or larger was associated with increased
cardiovascular events (relative risk [RR] 2.8, 95% confidence interval [CI], 1.01-5.24) independent of other risk factors,
including initial AAA diameter, but was only of borderline significance when patients were censored at the time of AAA
repair (RR, 2.35; 95% CI, 0.98-5.63). In the subset of patients with CTA follow-up, the median annual increase in AAA
volume was 5.1 cm3 (IQR, 0.8-10.3 cm3). Annual AAA volume increase was positively correlated with initial AAA diameter
(r0.44,P .006) and thrombus volume (r0.50,P .001).Median or larger aortic thrombus volumewas associatedwith
rapid AAA volume increase (>5 cm/y), independent of initial aortic diameter (RR, 15.0; 95% CI, 1.9-115.7; P  .009).
Conclusion: In this small cohort, infrarenal aortic thrombus volume was associated with the incidence of cardiovascular
events and AAA progression. These results need to be confirmed and mechanisms underlying the associations clarified in
large further studies. ( J Vasc Surg 2011;53:28-35.)Abdominal aortic aneurysms (AAA) are a common pa-
thology affecting approximately 7% of men and 1% of women
aged65 years.1 Patients who have AAAs have two principal
concerns. Firstly, AAAs are associated with an excess risk of
death and cardiovascular complications, such as myocardial
infarction and ischemic stroke,2,3 distinct from the risk ofAAA
rupture. Secondly, AAAs tend to expand over time to a size
often requiring surgery and where AAA rupture is more
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28prevalent.4 Previous studies indicate that about 60% of small
AAAs measuring 40 mm enlarge to a diameter requiring
surgery within 5 years.5,6
The determinants of AAA progression and cardiovascular
events in these patients are currently poorly defined. Themost
consistent prognostic factor for cardiovascular events and
AAA progression is the initial AAA diameter.2,3-14 AAA is
usually associatedwith intraluminal thrombus, which contains
leukocytes, proinflammatory cytokines, and proteolytic en-
zymes and is implicated in AAA development, progression,
and rupture.15-23 AAA thrombus products are also released
into the circulation, where they have potential to stimulate
leukocytes and other changes that might promote atheroscle-
rotic plaque activation and acute coronary and cerebrovascular
events.24-28 To our knowledge, no previous study has exam-
ined the association of AAA thrombus with subsequent car-
diovascular events; thus, the study had two aims:
● Aim 1: Examine the association of AAA thrombus
volume with future cardiovascular events.
● Aim 2: Assess the association of AAA thrombus with
AAA growth.
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Ethics approval for this study was provided by Human
Research Ethics Committees of the Townsville Health Ser-
vice District and James Cook University.
Patients and clinical definitions. Patients were pro-
spectively recruited from the vascular surgery clinic at The
Townsville Hospital, Queensland, Australia, between May
2003 and July 2008. Inclusion criteria included:
1. Verbal and written informed consent;
2. A computed tomography angiogram (CTA) by the
treating physician to further assess the patients, with
indications for CTA including aneurysm morphology
assessment before surgery, inadequate ultrasound as-
sessment, requirement for more detailed AAA diameter
assessment, and analysis of concurrent atherothrombo-
sis; and
3. An initial maximal axial infrarenal aortic diameter of
30 mm measured on CTA.
Exclusion criteria included refusal to participate, previous
surgical repair of the abdominal aorta, and contraindication
to CTA, such as abnormal serum creatinine concentration
and contrast allergy. Numbers and demographics of pa-
tients excluded were not recorded.
Intermittent claudication was diagnosed by a consul-
tant vascular physician from an appropriate history along
with clinical signs of lower limb ischemia andCTA evidence
of occlusive or stenotic peripheral artery disease. Hyperten-
sion and diabetes were defined by history or treatment for
these conditions. Cigarette smoking classification was
based on smoking history and defined ultimately as ever or
never smoked. Coronary heart disease (CHD) was defined
by a history of myocardial infarction, angina, or coronary
revascularization. Body mass index (BMI) was calculated as
kg/m2.
CT angiography. Contrast-enhanced CT images
were obtained using a 64-slice multiscanner (Philips, North
Ryde, NSW, Australia), under a set acquisition protocol.
The images were recorded at 3-mm intervals, with a slice
thickness of 3-mm, to construct 3-mm contiguous image
slices for analysis. A contrast agent (100 mL; Ultravist 300,
Bayer, Wayne NJ), delivered by an automatic CT injection
driver system (MEDRAD,Warrendale, Pa) was given intra-
venously. A low dose preliminary CT locater was set above
the renal arteries, which triggered the CTA when the
Hounsfield unit (HU) at the center of the aorta reached
130 after the delivery of the contrast agent.
Workstation protocols. AAA thrombus volume was
measured using a previously validated protocol with an
interobserver coefficient of variation of about 5%.29 Images
from the origin of the lowest renal artery (excluding acces-
sory arteries) to the bifurcation of the aorta were transferred
to MxView Visualization Workstation software (Philips,
Bothell, Wash) for analysis. Previously definedHUs (center
level, 0 HU; window width, 140 HU) were used for the
thrombus threshold. The volume-of-interest tool was used
to draw an encircling line around the aorta to form a regionof interest. The region of interest was individually drawn for
each slice to ensure that only the aorta was included.
The selected images were saved onto the workstation
and reloaded into the three-dimensional (3D) mode. The
software program computed the volume of thrombus in
cm3. Maximal axial infrarenal aortic diameter was assessed
using the “CTA viewer function” on the Philips Worksta-
tion. The region was scouted to find the area of maximal
diameter, taking many measurements with electronic cali-
pers. Maximal diameter was recorded in millimeters (to the
nearest 0.1 mm).
Clinical data. The following information was col-
lected by a vascular physician at entry into the study: sex,
age, height, weight, smoking status, diabetes mellitus, hy-
pertension, CHD, and medication history. After the initial
consultation, a CTA was arranged and the patients were
subsequently monitored according to the AAA diameter.
Follow-up was yearly for patients with small AAAs measur-
ing 30 to 39 mm and every 6 months for those with an
initial AAA diameter 40 mm. The primary outcome re-
corded during follow-up was admission for cardiovascular
events (nonfatal stroke, nonfatal myocardial infarction, cor-
onary revascularization, amputations, and cardiovascular
death) to assess aim 1. Outcome data were recorded during
follow-up visits and subsequently checked by review of
patients’ records by two independent researchers (for all
patients) and by additional phone calls to selected patients
who had no chart entry in previous 2 years and whose
primary residence was outside The Townsville Hospital
catchment area. Ultrasound imaging was used to monitor
most AAAs, but some patients underwent repeat CTA
because of concern that the AAA had expanded to a size
requiring surgery, difficulty in imaging by ultrasound, or
concern over the accuracy of the ultrasound imaging. Only
patients undergoing repeat CTA were included to assess
aim 2 due to the lack of comparability between diameters
derived by ultrasound imaging and CT.30
Growth measurements. Initial and follow-up CTAs
were assessed for maximal axial infrarenal aortic diameter
and total infrarenal aortic volume using previously validated
techniques.29 These measurements were used to calculate
the weighted annual change in AAA volume. We used this
assessment method because we have previously found vol-
ume is more sensitive to change than diameter.31
Statistical analysis. Data were prospectively entered
into an Excel spreadsheet (Microsoft, Redmond, Wash)
and later transferred to SPSS 17 software (SPSS Inc, Chi-
cago, Ill) for further analysis.
To assess aim 1, the total cohort of patients was in-
cluded. Median initial aortic thrombus in this group was
29.6 cm3 (interquartile range [IQR], 13.6-54.5). Aortic
thrombus volume of small (thrombus volume 25.0 cm3)
and large (thrombus volume 25.0 cm3) was defined by
rounding down thrombus median to the nearest 5 cm3.
To assess aim 2, the 39 patients with a repeat CTA
assessment were included. Median initial aortic thrombus
in this group was 16.4 cm3 (IQR, 10.6-32.0 cm3). Aortic
thrombus was defined as small (thrombus volume 15.0
pared
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ing down thrombus median to the nearest 5 cm3.
Initially continuous variables were assessed using
Kolmogorov-Smirnov test, histograms, and normal
quantile-quantile plots, which demonstrated that they were
not normally distributed. Continuous variables were com-
pared with Mann-Whitney U test and nominal variables
with the Fischer exact test. Kaplan-Meier analysis was used
to determine freedom from cardiovascular events.
In the primary analysis, patients were censored at loss
to follow-up or death from causes other than cardiovas-
cular events. In a secondary analysis, patients were also
censored at the time of AAA repair to exclude confound-
ing effects of surgical intervention. Cox proportional
analysis was used to assess the effects of known risk
factors on cardiovascular events. Relative risk (RR) is
presented with 95% confidence intervals (CI). Categoric
variables were dummy-coded. Known risk factors exam-
ined for inclusion in the final model were age, gender,
smoking status, diabetes mellitus, hypertension, dyslipi-
demia, CHD, maximal axial infrarenal aortic diameter,
intermittent claudication, and use of calcium channel
blockers, statins, warfarin, aspirin, angiotensin convert-
ing enzyme inhibitor, and -blockers.
Association of risk factors with cardiovascular events
was examined with a stepwise selection procedure using
backward and forward likelihood ratios. Variables not in
the stable model were included individually in the
model. Risk factors that led to a 10% change in the
coefficient of the model were retained in the final model
as a potential confounder. Variables not included in the
final model did not significantly affect the results. Deter-
minants of rapid AAA growth were assessed using logis-
Table I. Risk factors of patients at recruitment in relation
Characteristica Total
Patients 98
Age, years 73 (67-77)
Male 75 (76.5)
Follow-up, years 3.0 (2.0-3.6)
Max AAA axial diameter, mm 47.2 (34.9-54.6)
Body mass index, kg/m2 28.2 (25.0-30.8)
Intermittent claudication 29 (29.6)
Diabetes mellitus 20 (20.4)
Ever smoked 86 (87.8)
Hypertension 75 (76.5)
Coronary heart disease 59 (60.2)
Medication use
Warfarin 13 (13.3)
Aspirin 62 (63.3)
Calcium channel blocker 24 (24.5)
ACE inhibitor 42 (42.9)
Statin 65 (66.3)
-Blocker 35 (35.7)
ACE, Angiotensin-converting enzyme.
aContinuous results are presented as medians (interquartile range) and com
are compared by Fisher exact test (two-tailed significance).tic regression.RESULTS
Characteristics of patients at recruitment. The risk
factors of the 98 patients in relation to the volume of
infrarenal AAA thrombus are reported in Table I. The
median infrarenal axial AAA diameter was 47.2 mm, and 19
patients had an AAA with axial diameter 55 mm at study
entry. Thrombus volume was greater in large AAAs, men,
and in patients who did not have intermittent claudication
(Table I). Thrombus volume was not associated with war-
farin or aspirin use.
Cardiovascular events. Patients were monitored for a
median of 3.0 years (IQR, 2.0-3.6 years). Cardiovascular
events that occurred during follow-up were nonfatal myo-
cardial infarction in 13, coronary revascularization in 4,
stroke in 1, below knee amputation in 1, and cardiovascular
death in 9. Patients with a large volume of AAA thrombus
had a higher incidence of cardiovascular events (Fig 1). The
incidence of cardiovascular events at 4 years in patients with
small compared with large AAA thrombus was 23.4% (95%
CI, 16.0%-30.8%) vs 49.2% (95% CI, 39.8-58.6), respec-
tively (P .040). The incidence of cardiovascular events at
4 years in patients with small vs large maximal AAA diam-
eters was 24.5% (95% CI, 16.7%-32.3%) vs 46.6% (95% CI,
37.9-55.3), respectively (P  .074; Fig 2). AAA thrombus
volume25.0 cm3 was associated with increased incidence
of new cardiovascular events independent of other risk
factors by Cox analysis (RR, 2.3; 95% CI, 1.01-5.24; Table
II). Sex was identified as a confounding factor. All other
variables, including initial AAA diameter, did not signifi-
cantly affect the results.
AAA surgery. During follow-up, 37 patients under-
dominal aortic aneurysm (AAA) thrombus volumes
ombus 25.0 cm3 Thrombus 25.0 cm3 P
43 55
72 (67-75) 74 (68-78) .245
28 (65.1) 47 (85.5) .029
.2 (2.0-3.7) 2.8 (1.9-3.4) .358
.4 (32.2-42.6) 52.8 (49.5-58.1) .001
.7 (25.6-32.0) 27.8 (24.5-30.3) .150
18 (41.9) 11 (20.0) .026
8 (18.6) 12 (21.8) .803
36 (83.7) 50 (90.9) .357
33 (76.7) 42 (76.4) .99
25 (58.1) 34 (61.8) .836
7 (16.3) 6 (10.9) .552
27 (62.8) 35 (63.6) .99
13 (30.2) 11 (20.0) .344
22 (51.2) 20 (36.4) .156
24 (55.8) 41 (74.5) .057
18 (41.9) 17 (30.9) .293
by Mann-Whitney U test; nominal results are presented as number (%) andto ab
Thr
3
34
28went AAA repair, comprising 12 open and 25 by endovas-
mes.
s. *C
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secondary analysis of cardiovascular events examined the
association of AAA thrombus, censoring these patients at
AAA repair. The findings of this analysis were similar to the
primary analysis. The incidence of cardiovascular events at 4
years for patients with small compared with large AAA
Fig 1. Kaplan-Meier analysis shows freedom from cardi
(26.0 cm3) abdominal aortic aneurysm thrombus volu
Fig 2. Kaplan-Meier analysis shows freedom from car
large-diameter (45.0 mm) abdominal aortic aneurysmthrombus volumes was 26.9% (95% CI, 18.3-35.5) vs48.9% (95% CI, 40.6-59.5), respectively (P  .049). The
incidence of cardiovascular events at 4 years for patients
with small compared with large maximal axial AAA diame-
ters was 26.1% (95% CI, 17.5-34.7) vs 48.6% (95% CI,
38.1%-59.1%), respectively (P  .065). Patients with AAA
thrombus volume25.0 cm3 had an increased incidence of
ular events in patients with small (26.0 cm3) and large
*Cardiovascular event rate at 4 years.
scular events in patients with small- (45.0 mm) and
ardiovascular event rate at 4 years.ovascdiovacardiovascular events (RR, 2.35; 95% CI, 0.98-5.63) after
eter w
pared
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was no longer significant (P  .056).
AAA growth. Repeat CT scans of the AAAs were
done in 39 patients a median of 1.5 years (IQR, 1.1-3.3
years) after their initial imaging and before any surgery.
Included in these 39 are 15 patients who were selected for
AAA repair and another 24 patients whose treating physi-
cians decided to obtain a further CT. The risk factors of the
39 patients who underwent repeat CTA in relation to slow
(5 cm3) and rapid (5 cm3) annual abdominal aortic
volume expansion are reported Table III. Rapid expansion
was associated with larger initial AAA diameter and throm-
bus volume (P  .001). Annual median (IQR) AAA vol-
ume was 5.1 cm3 (0.8-10.3 cm3), and diameter increase
was 1.3 mm (0.2 to 2.7 mm). Annual abdominal aortic
volume change was positively correlated with maximal axial
initial AAA diameter (r  0.44, P  .006) and thrombus
volume (r 0.50, P .001; Fig 3). Initial AAA thrombus
volume 15.0 cm3 was associated with rapid volumetric
growth 5 cm2/y (RR, 15.0; 95% CI, 1.9-115.7, P 
Table II. Cox proportional analysis examining prognostic
Prognostic factor Sample size (n  98) Card
Thrombus volume
25.0 cm3 43
25.0 cm3 55
Sexa
Male 75
Female 23
Max axial aortic diameterb
45.0 mm 42
45.0 mm 56
CI, Confidence interval; RR, relative risk.
aIdentified as a confounder (ie, 10% change in thrombus coefficient).
bNot identified as a confounder but included to illustrate the effect of diam
Table III. Risk factors of patients at recruitment in relatio
exceeding the median or below the median
Characteristica Total
Patients 39
Age, years 73 (69-77)
Male 27 (69.2)
Follow-up, years 1.5 (1.1-3.3)
Max AAA diameter, mm 42.1 (33.0-47.0)
Total AAA volume, cm3 73.6 (46.6-95.2)
Thrombus volume 16.4 (10.6-32.0)
Warfarin 2 (5.1)
Intermittent claudication 15 (38.5)
Diabetes mellitus 9 (23.1)
Ever smoked 32 (82.1)
Hypertension 29 (74.4)
Coronary heart disease 22 (56.4)
aContinuous results are presented as medians (interquartile range) and com
are compared by the Fisher exact test (two-tailed significance)..009). Initial AAA diameter, smoking, and diabetes melli-tus were not significantly associated with rapid growth after
adjusting for thrombus volume.
DISCUSSION
The main finding of this study was that the volume of
AAA thrombus was associated with subsequent cardiovas-
cular events and rapid AAA growth. This association was
independent of initial AAA diameter, at least in our primary
analysis. Few previous studies have examined the associa-
tion of thrombus quantity with AAA growth,18,19 and we
are unaware of any previous investigation that has examined
the relationship of thrombus volume and cardiovascular
outcomes.
Large AAA diameter has been independently associated
with increased risk of perioperative cardiovascular compli-
cations32 and 3-year cardiovascular death2,33 after endolu-
minal aneurysm repair. A similar association is found in
patients whose small AAAs were treated conserva-
tively.2,3,7-9 Five large studies have reported that initial
abdominal aortic diameter predicts future cardiovascular
rs for cardiovascular events
ular events, No. (n  28) RR (95% CI) P
8 1 (Ref) .046
20 2.30 (1.01-5.24)
19 1 (Ref) .115
9 1.95 (0.85-4.46)
8 1 (Ref) .857
20 1.1 (0.27-4.72)
hen thrombus is included in analysis.
abdominal aortic aneurysm (AAA) expansion at or
Annual AAA volume increase
P5.0 cm3/y 5.0 cm3/y
19 20
4 (69-77) 71 (68-75) .518
3 (68.4) 14 (70.0) .981
.4 (0.9-3.3) 1.6 (1.1-3.3) .771
.0 (30.3-43.3) 44.8 (41.0-49.3) .001
.6 (40.4-60.0) 86.0 (75.2-107.3) .001
.1 (9.2-13.7) 27.1 (21.4-44.3) .001
1 (5.3) 1 (5.0) .99
0 (52.6) 5 (25.0) .105
6 (31.6) 3 (15.0) .237
5 (78.9) 17 (85.0) .695
6 (84.2) 13 (65.0) .273
4 (73.7) 8 (40.0) .054
by Mann-Whitney U test; nominal results are presented as number (%) andfacto
iovascn to
7
1
1
22
49
11
1
1
1
1events,7-9 all-cause mortality,3,7,8 and cardiovascular mor-
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there are convincing data of the association between aortic
diameter and cardiovascular events; however, the reason for
this association is currently unknown.
A recent study by our group found thrombus volume
was closely correlated with maximum axial aortic diameter
(r  0.74; P  .0001) in patients with AAA or aortic
ectasia.29 This association between AAA diameter and
thrombus is in keeping with the findings of previous smaller
studies.34,35 Currently, the factors determining thrombus
deposition are not known and were not examined in this
study. AAA thrombus products have been demonstrated
within the systemic circulation and have potential to influ-
ence pathways implicated in atherothrombosis.24-28 We
therefore postulated that AAA thrombus products could be
one of a number of causal links between aortic diameter and
cardiovascular events. Our findings support this hypothesis
and suggest the association between AAA thrombus and
outcome warrants further assessment in larger studies.
Initial AAA diameter is recognized as the most power-
ful and consistent predictor of AAA growth.4,5,11,13,36-41
Two previous studies have examined the association be-
tween AAA thrombus and growth.18,19 Wolf et al19 re-
viewed CT scans of 80 patients who underwent repeat CT
scans 6 months apart. On the section with the largest
cross-sectional diameter, the researchers used hard copy
images to measure maximal diameter, aneurysm area, lu-
men area, thrombus thickness, and arc of aortic wall cov-
ered by thrombus and calculated AAA volume, thrombus
volume, and thrombus percentage. They reported that
large thrombus arc, thrombus percentage, and thrombus
area were highly significantly associated with increased
AAA expansion (P  .001 in all variables). There was no
report of the reproducibility of the measurement tech-
niques used and the association was not adjusted for initial
AAA diameter. A recent longitudinal prospective study18
Fig 3. Scatterplots display the association of annual abd
(B) maximal axial abdominal aortic diameter.examined 195 AAA patients (range, 40-49 mm) with twoCT scans 6 months apart. The authors assessed continu-
ous (increased growth rates) vs discontinuous growth. An-
eurysms with no thrombus or concentric thrombus were
associated exclusively with discontinuous and slower
growth rates (P  .05). These two previous studies, along
with the current investigation, provide support for a role of
thrombus in AAA progression.
AAA thrombus has been demonstrated to contain large
numbers of polymorphonuclear leukocytes and high con-
centrations of matrix metalloproteinases, elastase, and plas-
min.16,17,42 Elastase has been suggested to inhibit mesen-
chymal cells binding to fibrin and thereby impair repair of
aortic injury.43 Plasmin activation of matrix metallopro-
teinases at the thrombus and aortic wall interface has been
postulated to enhance proteolysis.16 These mechanisms
provide a potential link between AAA thrombus and pro-
gression. In keeping with these findings, a recent study
reported an association between reduced small AAA pro-
gression and aspirin prescription, and two preclinical stud-
ies have suggested that antiplatelet interventions inhibit
AAA progression.44-46
In our primary assessment of risk factors for cardiovas-
cular events, we did not censor patients at the time of AAA
repair because these events are still common after surgery.
In a secondary analysis, we censored patients who required
AAA repair at the time of surgery. The findings of this
analysis were similar to our primary assessment, except that
the association of thrombus volume with cardiovascular
events adjusted for other risk factors was only of borderline
significance.
The current study has a number of limitations. Firstly,
the small sample size made analysis difficult. Interaction
terms could not be used to assess the relationship between
thrombus and AAA diameter in relation to cardiovascular
events. The results may be confounded by the relationship
al aortic volume change with (A) thrombus volume andominbetween thrombus and AAA diameter, in addition to other
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aspect before any conclusions can be reached.
Secondly, follow-up periods were short. Larger studies
with longer-term follow-up are required to confirm the
associations we report.
Thirdly, a large portion of patients in the high throm-
bus group had an AAA repair, potentially confounding
results.
Fourthly, volumetric analysis of thrombus may have
certain limitations. Because the length of the infrarenal
aorta varies between individuals, this method may overes-
timate the thrombus burden in patients with greater
length. However, because volumetric analysis assesses
thrombus quantity, this should provide an estimation of the
thrombus available for potential thrombus-derived product
production and release into the circulation.
Finally, the findings of this study are based on patients
with AAA who underwent CT assessment only. Whether
the findings can be related to all small AAAs remains to be
established.
CONCLUSIONS
To our knowledge, this is the first study to demonstrate
an association between AAA thrombus volume and subse-
quent cardiovascular events. This association could reflect
cardiovascular risk factors we have not been able to adjust
for in this study or may result from the systemic effects of
circulating thrombus products. Further studies are required
to assess the clinical importance of the association.
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